Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2026

Conditions
Mild Cognitive ImpairmentSubjective Cognitive Decline
Interventions
DIAGNOSTIC_TEST

pCASL

Brain 3 Tesla MRI with pCASL sequence

Trial Locations (1)

20900

RECRUITING

Fondazione IRCCS San Gerardo dei Tintori, Monza

All Listed Sponsors
lead

University of Milano Bicocca

OTHER